Skip to main content

Humana Value Stock - Dividend - Research Selection

Humana

ISIN: US4448591028 , WKN: 856584

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program

2026-01-12
LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.

5 Considerations In The Upcoming CPI Report

2026-01-11
Stock indices rallied despite limited CPI data last month; since then, small-caps and Dow are outperforming tech into early 2026.

Humana (HUM) Valuation Check After Mixed Shareholder Returns And New Discount To Analyst Targets

2026-01-10
Humana (HUM) has been drawing fresh attention as investors reassess the health insurer’s recent share performance, with the stock showing mixed returns over the past year and over longer multiyear periods. See our latest analysis for Humana. Humana’s recent momentum has picked up, with a 7-day share price return of 4.68% and a 30-day share price return of 7.87%. However, the 3-year total shareholder return of 41.78% and 5-year total shareholder return of 28.76% remain weak. If Humana’s mixed...

How Recent Margin Concerns Are Shaping Humana’s (HUM) Evolving Valuation Story

2026-01-10
Humana's fair value estimate has been nudged from about US$288.46 to roughly US$287.38 per share, reflecting a more cautious stance around how quickly its government managed care businesses might settle into a steadier earnings rhythm. While the discount rate remains essentially unchanged at about 6.96% and revenue growth expectations are now around 9.65%, the mix of bullish and bearish views on Medicare Advantage and Medicaid is keeping opinions split on where the stock should trade. Stay...

Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

2026-01-09
LOUISVILLE, Ky., January 09, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.

2 Unpopular Stocks That Deserve Some Love and 1 We Question

2026-01-08
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Wells Fargo Downgrades Humana (HUM)

2026-01-08

Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls

2026-01-07
Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls

Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis

2026-01-06
DENVER, January 06, 2026--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives, joins UnitedHealthcare, Cigna, Humana, BCBS Kansas City, Excellus BCBS, and EviCore in providing coverage for this advanced technology.

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

2026-01-06
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque AnalysisMOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major national commercial ins